However, while molecular markers of cell damage such as S100B and neuron-specific enolase can be detected in the serum of migraine patients (Teepker et al., 2009; Yilmaz et al., 2011), no difference was found between MwA and MwoA patients that could reflect the structural damage that we have found. The gene discussed is ENO2; the disease is migraine disorder.